Abingdon Health is pleased to announce the launch of AppDx, a customisable Smartphone lateral flow reader suitable for integration with existing lateral flow assays or assays requiring development.
AppDx combines flexible and connective mobile phone technology to provide a rapid analytical testing solution in any testing location, enabling rapid decision making.
There is an increasing demand from GPs, clinicians, veterinarians, farmers and food safety professionals to receive real-time data from user-friendly devices. The AppDx App is able to meet this demand by using images of lateral flow device test lines taken with a Smartphone camera and translating the image into numerical data. The intuitive software is suitable for both Apple and Android phones removing the need for separate development for different mobile technologies.
Chris Yates, CEO of Abingdon Health, commented:
“We are launching our Smartphone reader technology at a time when the demand for mobile phone diagnostics continues to grow considerably.”
“We have developed AppDx to be entirely customisable by the end user, dependent on their assay requirements. The flexibility of using smartphone technology allows the transfer of real-time data and testing in any location.”
In introducing AppDx on to its lateral flow assay and reader services portfolio, Abingdon Health is able to further enhance its ability to provide its customers with a suite of rapid testing solutions to meet their individual user, quality and cost requirements.